Explaining the Five Classes of Antiretroviral Drugs for AIDS Patients
March 10th, 2011 by Aldouspi

Explaining the Five Classes of Antiretroviral Drugs for AIDS Patients

Research is still going on for treatments and vaccines that will help an AIDS patient. There is no cure for AIDS. Drugs are used to prolong and give the patient a better quality of life. A lot has been accomplished since the early 1980's when AIDS was first discovered, but scientists do not see a cure coming soon.

It takes years to find a drug that will work to either boost the immune system, or fight the destruction of the white blood cells. Clinical trials are still needed to find drugs that work and each individual will respond to these drugs in their own way.

Although there is no cure for AIDS, drugs have been developed to inhibit growth and reproduction of the HIV or human immunodeficiency virus. Five classes of drugs are available.

Nucleoside analogue reverse transcriptase inhibitors were the first antiretroviral drugs to be developed. They slow down the multiplication of an HIV enzyme called reverse transcriptase. This class includes the drugs, Retrovir, Epivir, Videx, Hivid, Zerit and Ziagen. These drugs must be used in a combination with two other AIDS drugs that will treat both HIV and hepatitis B.

There are serious side effects for each of these drugs. The symptoms will usually appear in the first few weeks of treatment and will disappear, if the drugs are stopped. Some side effects include vomiting, nausea, stomach pain, fatigue, and trouble breathing.

Protease inhibitors are drugs that will stop the HIV reproduction when the disease is in a later stage. This drug causes the HIV particles in your body to become non-organized and non-infectious. Drugs in this class are Norvir, Crixivan, Viracept, Reyataz, Aptivus Prezista and Agenerase.

Some patients who have not responded to other AIDS medications may respond with this class of drugs. Most are used with other AIDS medications.

The most common side effects of protease inhibitors are stomach and digestive problems such as diarrhea and vomiting. A problem with the metabolism of sugar is a side effect of some of the newer protease inhibitors.

The third-class of AIDS drugs is NNRTIs or non-nucleoside reverse transcriptase inhibitors. This class of drugs will bind to the enzyme reverse transcriptase. Side effects for this class include sleeplessness, abnormal dreams, trouble in concentrating, and dizziness.

The fourth class works much like the third-class. They prevent the virus from putting its genetic material into the cells. This class will work faster and are effective for patients who are resistant to NNRTIs. There can be a fatal complication of liver damage by taking this class of drugs for AIDS treatment.

Fusion inhibitors are drugs that are used on patients with a drug resistant form of HIV. Many people with AIDS are resistant to, at least, one drug and many will not respond to a three-drug combination.

These new classes of drugs called inhibitors are given by injection and suppress some resistant strains of the HIV virus. When you are being medicated with any of these classes of drugs, you will have your viral load tested every three to four months.




Antiretroviral Drugs Related Items For Sale

[phpbay]HIV Drug, 9, “”, “”[/phpbay]


Explaining the Five Classes of Antiretroviral Drugs for AIDS Patients

related articles from the blogosphere…

Access to Antiretroviral AIDS Drugs Worldwide

Nobel Laureate Francoise Barré-Sinoussi on the progressing in giving developing nations access to antiretroviral drugs and what obstacles may come in the future. In June 2011, Francoise Barré-Sinoussi, co-winner of the 2008 Nobel Prize in Physiology …


Antiretroviral Drugs Work ? This Is Why You Should Take Them

blog.lass.org.uk10/19/11

To provide you with the best chance of reducing the amount of HIV in your blood to very low levels, your doctor will recommend that you take a powerful combination of at least three antiretroviral drugs. Once your viral load

Bullying the Boss? Compulsory Licensing for Antiretroviral Drugs in

www.hcs.harvard.edu10/21/11

By Shaira Bhanji Global Health Finance Columnist Underdeveloped, HIV-burdened regions of the world have the potential to make strides toward better survival outcomes, but they lack key resources. Simple antiretroviral

Anti retroviral drugs of class protease inhibitors drugs

bvwaghmare.blogspot.com9/5/11

Antiretroviral drugs belonging to class protease inhibitors are known to cause increase in cholesterol level in patients taking protease inhibitors drugs. Anti retroviral protease inhibitors drugs which act by inhibiting enzyme





Some of the links in the post above are “affiliate links.” This means if you click on the link and purchase the item, we will receive an affiliate commission. Regardless, we only recommend products or services we believe will add value to our readers.

Comments are closed

SIDEBAR
»
S
I
D
E
B
A
R
«
Copyright Healthyhuman.net | Privacy Policy | Disclosure Policy »  Substance: WordPress   »  Style: Ahren Ahimsa